India has made strong progress in fighting HIV, but experts say it must do more. The AIDS Society of India, a group of doctors and researchers, says India should provide pre-exposure prophylaxis (PrEP) with lenacapavir, a new injectable drug that can prevent HIV if given twice a year. The United Nations reports 40.8 million people have HIV worldwide, with 2.54 million in India and 68,450 new cases in 2024. Thanks to effective antiretroviral therapy (ART), many living with HIV stay healthy. "The life expectancy of those receiving ART and are virology suppressed is almost similar to those without HIV," experts say. But India has not yet introduced PrEP, leaving a gap in efforts to stop new infections. Winnie Byanyima, UNAIDS Executive Director, said, "The HIV response has already saved 26.9 million lives worldwide. With an HIV prevention revolution, we could end AIDS as a public health threat, saving many more lives." Funding changes also challenge HIV programs. The US withdrawal of support in early 2025 disrupted treatment worldwide. India funds 95% of its HIV treatment and prevention efforts. The AIDS Society of India encourages the country to lead other low and middle-income nations by creating strong, government-led, and sustainable HIV programs. N. Kumarasamy, Vice President of the AIDS Society of India, highlighted the need for nationally owned, inclusive solutions to fight HIV effectively in the future.